http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6040343-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_241c3d4e236532a2e822eb39f56b1be9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-232
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 1997-01-17^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-03-21^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60a7726edb079b1b6225668578b71300
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66d09585330c30dc61d5c9fcc346154c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a512de9f7a1fbf05c3ebd953bcec339d
publicationDate 2000-03-21^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6040343-A
titleOfInvention Remedy for keratoconjunctival diseases
abstract PCT No. PCT/JP97/00081 Sec. 371 Date Jul. 17, 1998 Sec. 102(e) Date Jul. 17, 1998 PCT Filed Jan. 17, 1997 PCT Pub. No. WO97/26872 PCT Pub. Date Jul. 31, 1997The present invention provides a novel substance which promotes the production and secretion of mucin in ophthalmic tissues. The therapeutic agent for keratoconjunctiva diseases according to the present invention contains gefarnate as an active ingredient. This therapeutic agent for keratoconjunctiva diseases is applicable to dry eye, keratitis, conjunctivitis, corneal erosion, corneal ulcer, etc. The dosage form is preferably an ophthalmic solution. Concentration of gefarnate is, for example, 0.1-3% (w/v).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009270474-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004014812-A1
priorityDate 1996-01-22^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06192073-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226683910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226683909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22164851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129934270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73950587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18599331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226514189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420491

Showing number of triples: 1 to 49 of 49.